Mycosis Fungoides (MF)
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Metastatic Brain Tumors
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Glioblastoma
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Glioblastoma
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Newly Diagnosed High Grade Glioma (HGG)
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Medulloblastomas
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Hodgkin Disease
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Lymphoma, Non-Hodgkin
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Refractory Multiple Myeloma
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Ependymomas
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Brain Stem Gliomas
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional
Astrocytomas
, 3.0 mg/mL, 10.0 mg/mL, 5.0 mg/mL, 7.7 mg, 100.0 mg
, Injection, powder, lyophilized, for solution; Kit, Kit, For solution; Kit - Intravenous, Injection, powder, lyophilized, for solution; Kit - Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intravenous, Wafer, Powder, for solution - Intravenous, Intracavitary, Powder, for solution, Wafer - Intralesional, Wafer - Intracavitary, For solution; Kit, Kit - Intravenous, Intralesional